192 related articles for article (PubMed ID: 22649135)
1. [¹⁸F]Fluorodeoxyglucose positron emission tomography-guided therapy in metastatic adrenocortical carcinoma: an illustrative case.
Chuang HH; Deniz F; Sircar K; Jimenez C; Rubin De Celis C; Wood CG; Habra MA
J Clin Oncol; 2012 Sep; 30(26):e246-9. PubMed ID: 22649135
[No Abstract] [Full Text] [Related]
2. 18F-FDG PET reveals an adrenocortical carcinoma in a bilateral adrenal multinodular disease.
Libé R; Jazeron JF; Louiset E; Groussin L
Endocrine; 2019 Jan; 63(1):188-189. PubMed ID: 30251165
[No Abstract] [Full Text] [Related]
3. Adrenocortical Carcinoma Treated by CyberKnife.
Harada Y; Miyazaki S
Intern Med; 2016; 55(15):2031-4. PubMed ID: 27477410
[TBL] [Abstract][Full Text] [Related]
4. [A Case Report of a Patient with Metastatic Adrenocortical Carcinoma who Received the Combination Etoposide, Doxorubicin, Cisplatin, and Mitotane Therapy and Achieved Remission].
Ueda S; Nakane K; Namiki S; Takeuchi Y; Kawase M; Takeuchi S; Kawase K; Nakai C; Kato D; Takai M; Iinuma K; Tsuchiya T; Miyazaki T; Koie T
Hinyokika Kiyo; 2022 May; 68(5):139-143. PubMed ID: 35748231
[TBL] [Abstract][Full Text] [Related]
5. A concomitant false-negative ¹⁸F-FDG PET imaging in an adrenocortical carcinoma and a high uptake in a corresponding liver metastasis.
Ghander C; Tissier F; Tenenbaum F; Silvera S; Ragazzon B; Bertherat J; Bertagna X; Dousset B; Richard B; Legmann P; Groussin L
J Clin Endocrinol Metab; 2012 Apr; 97(4):1096-7. PubMed ID: 22319030
[No Abstract] [Full Text] [Related]
6. Abdominal wall metastasis after open resection of an adrenocortical carcinoma.
van Grevenstein WM; de Krijger RR; de Herder WW; Tilanus HW; Bonjer HJ
Eur J Surg; 2001 Nov; 167(11):871-3. PubMed ID: 11848245
[No Abstract] [Full Text] [Related]
7. [A Case of Adrenocortical Carcinoma Successfully Treated with Multimodal Therapy].
Bando S; Ishii G; Yamada H; Kimura T; Furuta N; Egawa S
Hinyokika Kiyo; 2016 Jan; 62(1):15-9. PubMed ID: 26932330
[TBL] [Abstract][Full Text] [Related]
8. ¹⁸F FDG PET/CT demonstration of IVC and right atrial involvement in adrenocortical carcinoma.
Senthil R; Mittal BR; Kashyap R; Bhattacharya A; Radotra BD; Bhansali A
Jpn J Radiol; 2012 Apr; 30(3):281-3. PubMed ID: 22180188
[TBL] [Abstract][Full Text] [Related]
9. 5th International ACC Symposium: Surgical Considerations in the Treatment of Adrenocortical Carcinoma: 5th International ACC Symposium Session: Who, When and What Combination?
Miller BS
Horm Cancer; 2016 Feb; 7(1):24-8. PubMed ID: 26728469
[TBL] [Abstract][Full Text] [Related]
10. Prostate-Specific Membrane Antigen Expression in Adrenocortical Carcinoma on 68Ga-Prostate-Specific Membrane Antigen PET/CT.
Arora S; Damle NA; Aggarwal S; Passah A; Behera A; Arora G; Bal C; Tripathi M
Clin Nucl Med; 2018 Jun; 43(6):449-451. PubMed ID: 29578871
[TBL] [Abstract][Full Text] [Related]
11. Lipiodol avid liver metastases from adrenocortical carcinoma; prospects for therapy?
Nye E; Butler P; Clingan PC; Morris DL
Anticancer Res; 2001; 21(2B):1445-7. PubMed ID: 11396229
[TBL] [Abstract][Full Text] [Related]
12. Functioning metastasis from adrenocortical carcinoma.
Cunha C; Donato S; Silva T; Leite V
BMJ Case Rep; 2022 Jan; 15(1):. PubMed ID: 35078872
[TBL] [Abstract][Full Text] [Related]
13. [A case of adrenal cortical carcinoma].
Oida T; Souma T; Doi H; Hida S; Takasu K
Hinyokika Kiyo; 2002 Nov; 48(11):667-70. PubMed ID: 12512139
[TBL] [Abstract][Full Text] [Related]
14. Whole-body positron emission tomographic scanning in patients with adrenal cortical carcinoma: comparison with conventional imaging procedures.
Ahmed M; Al-Sugair A; Alarifi A; Almahfouz A; Al-Sobhi S
Clin Nucl Med; 2003 Jun; 28(6):494-7. PubMed ID: 12917534
[No Abstract] [Full Text] [Related]
15. Percutaneous laser ablation of unresectable primary and metastatic adrenocortical carcinoma.
Pacella CM; Stasi R; Bizzarri G; Pacella S; Graziano FM; Guglielmi R; Papini E
Eur J Radiol; 2008 Apr; 66(1):88-94. PubMed ID: 17498906
[TBL] [Abstract][Full Text] [Related]
16. Conventional chemotherapy and emerging targeted therapy for advanced adrenocortical carcinoma.
Xu YZ; Zhu Y
Anticancer Agents Med Chem; 2013 Feb; 13(2):248-53. PubMed ID: 22934700
[TBL] [Abstract][Full Text] [Related]
17. Surgical management of adrenocortical carcinoma.
Ranvier GG; Inabnet WB
Endocrinol Metab Clin North Am; 2015 Jun; 44(2):435-52. PubMed ID: 26038210
[TBL] [Abstract][Full Text] [Related]
18. Preoperative 18F-FDG uptake is strongly correlated with malignancy, Weiss score, and molecular markers of aggressiveness in adrenal cortical tumors.
Gust L; Taieb D; Beliard A; Barlier A; Morange I; de Micco C; Henry JF; Sebag F
World J Surg; 2012 Jun; 36(6):1406-10. PubMed ID: 22131094
[TBL] [Abstract][Full Text] [Related]
19. Current Status and Future Targeted Therapy in Adrenocortical Cancer.
Alyateem G; Nilubol N
Front Endocrinol (Lausanne); 2021; 12():613248. PubMed ID: 33732213
[TBL] [Abstract][Full Text] [Related]
20. A phase II trial of combination chemotherapy and surgical resection for the treatment of metastatic adrenocortical carcinoma: continuous infusion doxorubicin, vincristine, and etoposide with daily mitotane as a P-glycoprotein antagonist.
Abraham J; Bakke S; Rutt A; Meadows B; Merino M; Alexander R; Schrump D; Bartlett D; Choyke P; Robey R; Hung E; Steinberg SM; Bates S; Fojo T
Cancer; 2002 May; 94(9):2333-43. PubMed ID: 12015757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
